Essex Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$6.12M |
| 2 |
CRISPR Therapeutics
CRSP
|
+$5.37M |
| 3 |
Sensata Technologies
ST
|
+$5.01M |
| 4 |
DarioHealth
DRIO
|
+$3.05M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$3.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teladoc Health
TDOC
|
+$8.61M |
| 2 |
SPWR
SunPower Corporation Common Stock
SPWR
|
+$6.72M |
| 3 |
VeriSign
VRSN
|
+$5.32M |
| 4 |
BioLife Solutions
BLFS
|
+$4.9M |
| 5 |
Fulgent Genetics
FLGT
|
+$4.74M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.55% |
| 2 | Healthcare | 17.09% |
| 3 | Industrials | 12.67% |
| 4 | Materials | 10.49% |
| 5 | Consumer Discretionary | 9.85% |
Similar funds
Essex Investment Management's Q1 2021 Portfolio in Review
As of Q1 2021, Essex Investment Management held 537 positions worth $820M, up 1.8% from $806M the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Essex Investment Management withdrew a net $58.3M in Q1 2021, closing 92 positions and reducing 203 holdings. Its most notable exit was VeriSign, an estimated $5.32M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Essex Investment Management opened a new position in CRISPR Therapeutics worth $4.33M.
- Essex Investment Management's largest Q1 2021 buy was CRISPR Therapeutics: 35,540 shares worth $4.33M.
- Essex Investment Management added most to AT&T in Q1 2021, an estimated $6.12M increase.
- Essex Investment Management's biggest Q1 2021 reduction was Teladoc Health, cutting an estimated $8.61M.
- Essex Investment Management fully exited VeriSign in Q1 2021, selling an estimated $5.32M.
- Essex Investment Management's ten largest holdings make up 15% of its $820M portfolio in Q1 2021.
- Essex Investment Management opened 56 new positions and closed 92 in Q1 2021.
- Essex Investment Management's portfolio value rose 1.8% quarter-over-quarter to $820M.
Based on Essex Investment Management's 13F filing for Q1 2021, filed 12 May 2021.